While our findings implicate PBLD1 and MBNL3 in EAE-associated immune regulation, their pathophysiological significance in human MS requires validation through microglia-specific knockout models and analysis of MS patient datasets. This evidence concerns the gene MBNL3 and myeloid sarcoma.